Agios Pharmaceuticals | AGIO - 利息收入

金融业

USD

USD 1.18B

现金及等价物

USD 113.6M

USD 1.32M

USD 834.84M

USD 58.85M

USD 40.21M

USD -110.03M

USD -120.31M

486

EPS每股收益

USD -1.69

股本和储备

USD 1.11B

USD 18.09M

债务利息支出

USD 1.18B

USD 12.41M

USD 1.06M

USD 1.53B

USD -99.11M

USD 130.77M

USD -110.03M

普通股股本

USD 59.34M

3.56

USD -109.06M

USD 18.8M

销售和管理费用

USD 38.46M

USD 35.09M

贸易债权人

USD 13.75M

应收帐款人

USD 16.13M

	利息收入	更改		日
AbbVie	USD 59M		13M	2025-12
Agios Pharmaceuticals	USD 12.41M		959K	2025-12
Alnylam Pharmaceuticals	USD 28.68M		1.19M	2025-09
Arrowhead Research	USD 9.05M		1.97M	2025-09
Astellas Pharma	JPY 4.12B		2.94B	2024-03
AstraZeneca	USD 135M		50M	2025-12
Bayer	EUR 130M		38M	2025-09
Biogen	USD 37.2M		5.6M	2025-12
BioMarin Pharmaceutical	USD 17.85M		973K	2025-09
Daiichi Sankyo	JPY 9.96B		230M	2024-03
Eli Lilly	USD 65M		25M	2025-09
Exelixis	USD 15.92M		867K	2025-09
Gilead Sciences	USD 95M		7M	2025-12
GlaxoSmithKline	GBP -74M		100M	2025-12
Incyte	USD 30.75M		3.97M	2025-12
Ionis Pharmaceuticals	USD -0.66		0.29	2024-12
Merck	USD 96M		27M	2025-09
Moderna	USD 73M		8M	2025-09
Nektar Therapeutics	USD -0.18		0.07	2024-09
Pfizer	USD 0.62		156M	2025-09
Puma Biotechnology	USD 0.41		0.5	2024-09
Regeneron Pharmaceuticals	USD 193.3M		18.2M	2025-12
Sarepta Therapeutics	USD 8.38M		1.24M	2025-09
Vertex Pharmaceuticals	USD 125.7M		3.3M	2025-09